Literature DB >> 22555282

Pioneer factors in hormone-dependent cancers.

Kamila M Jozwik1, Jason S Carroll.   

Abstract

Pioneer factors are a special class of transcription factor that can associate with compacted chromatin to facilitate the binding of additional transcription factors. The function of pioneer factors was originally described during development; more recently, they have been implicated in hormone-dependent cancers, such as oestrogen receptor-positive breast cancer and androgen receptor-positive prostate cancer. We discuss the importance of pioneer factors in these specific cancers, the discovery of new putative pioneer factors and the interplay between these proteins in mediating nuclear receptor function in cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22555282     DOI: 10.1038/nrc3263

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  45 in total

1.  Forkhead box A1 (FOXA1) is a key mediator of insulin-like growth factor I (IGF-I) activity.

Authors:  Adam S Potter; Angelo J Casa; Adrian V Lee
Journal:  J Cell Biochem       Date:  2012-01       Impact factor: 4.429

2.  AP-2γ regulates oestrogen receptor-mediated long-range chromatin interaction and gene transcription.

Authors:  Si Kee Tan; Zhen Hua Lin; Cheng Wei Chang; Vipin Varang; Kern Rei Chng; You Fu Pan; Eu Leong Yong; Wing Kin Sung; Win King Sung; Edwin Cheung
Journal:  EMBO J       Date:  2011-05-13       Impact factor: 11.598

Review 3.  Androgen receptor signaling in androgen-refractory prostate cancer.

Authors:  M E Grossmann; H Huang; D J Tindall
Journal:  J Natl Cancer Inst       Date:  2001-11-21       Impact factor: 13.506

4.  The initiation of liver development is dependent on Foxa transcription factors.

Authors:  Catherine S Lee; Joshua R Friedman; James T Fulmer; Klaus H Kaestner
Journal:  Nature       Date:  2005-06-16       Impact factor: 49.962

5.  Estrogen receptor positive breast cancer metastasis: altered hormonal sensitivity and tumor aggressiveness in lymphatic vessels and lymph nodes.

Authors:  Joshua Chuck Harrell; Wendy W Dye; D Craig Allred; Paul Jedlicka; Nicole S Spoelstra; Carol A Sartorius; Kathryn B Horwitz
Journal:  Cancer Res       Date:  2006-09-15       Impact factor: 12.701

6.  Transducin-like enhancer protein 1 mediates estrogen receptor binding and transcriptional activity in breast cancer cells.

Authors:  Kelly A Holmes; Antoni Hurtado; Gordon D Brown; Rosalind Launchbury; Caryn S Ross-Innes; James Hadfield; Duncan T Odom; Jason S Carroll
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-02       Impact factor: 11.205

7.  Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer.

Authors:  Qianben Wang; Wei Li; Yong Zhang; Xin Yuan; Kexin Xu; Jindan Yu; Zhong Chen; Rameen Beroukhim; Hongyun Wang; Mathieu Lupien; Tao Wu; Meredith M Regan; Clifford A Meyer; Jason S Carroll; Arjun Kumar Manrai; Olli A Jänne; Steven P Balk; Rohit Mehra; Bo Han; Arul M Chinnaiyan; Mark A Rubin; Lawrence True; Michelangelo Fiorentino; Christopher Fiore; Massimo Loda; Philip W Kantoff; X Shirley Liu; Myles Brown
Journal:  Cell       Date:  2009-07-23       Impact factor: 41.582

Review 8.  Endocrine-responsive breast cancer and strategies for combating resistance.

Authors:  Simak Ali; R Charles Coombes
Journal:  Nat Rev Cancer       Date:  2002-02       Impact factor: 60.716

Review 9.  Pioneer transcription factors: establishing competence for gene expression.

Authors:  Kenneth S Zaret; Jason S Carroll
Journal:  Genes Dev       Date:  2011-11-01       Impact factor: 11.361

10.  PBX1 genomic pioneer function drives ERα signaling underlying progression in breast cancer.

Authors:  Luca Magnani; Elizabeth B Ballantyne; Xiaoyang Zhang; Mathieu Lupien
Journal:  PLoS Genet       Date:  2011-11-17       Impact factor: 5.917

View more
  122 in total

1.  Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression.

Authors:  Bing Song; Su-Hong Park; Jonathan C Zhao; Ka-Wing Fong; Shangze Li; Yongik Lee; Yeqing A Yang; Subhasree Sridhar; Xiaodong Lu; Sarki A Abdulkadir; Robert L Vessella; Colm Morrissey; Timothy M Kuzel; William Catalona; Ximing Yang; Jindan Yu
Journal:  J Clin Invest       Date:  2018-12-18       Impact factor: 14.808

Review 2.  Structural and functional characterization of aromatase, estrogen receptor, and their genes in endocrine-responsive and -resistant breast cancer cells.

Authors:  Hei Jason Chan; Karineh Petrossian; Shiuan Chen
Journal:  J Steroid Biochem Mol Biol       Date:  2015-08-13       Impact factor: 4.292

3.  uc.38 induces breast cancer cell apoptosis via PBX1.

Authors:  Lin-Xin Zhang; Lu Xu; Chen-Han Zhang; Yi-Han Lu; Tian-Hao Ji; Li-Jun Ling
Journal:  Am J Cancer Res       Date:  2017-12-01       Impact factor: 6.166

4.  Distinct Roles for BET Family Members in Estrogen Receptor α Enhancer Function and Gene Regulation in Breast Cancer Cells.

Authors:  Shino Murakami; Rui Li; Anusha Nagari; Minho Chae; Cristel V Camacho; W Lee Kraus
Journal:  Mol Cancer Res       Date:  2019-09-24       Impact factor: 5.852

5.  ERα Binding by Transcription Factors NFIB and YBX1 Enables FGFR2 Signaling to Modulate Estrogen Responsiveness in Breast Cancer.

Authors:  Thomas M Campbell; Mauro A A Castro; Kelin Gonçalves de Oliveira; Bruce A J Ponder; Kerstin B Meyer
Journal:  Cancer Res       Date:  2017-11-27       Impact factor: 12.701

6.  FoxC1 promotes epithelial-mesenchymal transition through PBX1 dependent transactivation of ZEB2 in esophageal cancer.

Authors:  Xiaoming Zhu; Li Wei; Yangqiu Bai; Sen Wu; Shuangyin Han
Journal:  Am J Cancer Res       Date:  2017-08-01       Impact factor: 6.166

Review 7.  Rationale for the development of alternative forms of androgen deprivation therapy.

Authors:  Sangeeta Kumari; Dhirodatta Senapati; Hannelore V Heemers
Journal:  Endocr Relat Cancer       Date:  2017-05-31       Impact factor: 5.678

Review 8.  Nuclear receptors in bone physiology and diseases.

Authors:  Yuuki Imai; Min-Young Youn; Kazuki Inoue; Ichiro Takada; Alexander Kouzmenko; Shigeaki Kato
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

9.  GATA4 is essential for bone mineralization via ERα and TGFβ/BMP pathways.

Authors:  Miriam Güemes; Alejandro J Garcia; Diana Rigueur; Stephanie Runke; Weiguang Wang; Gexin Zhao; Victor Hugo Mayorga; Elisa Atti; Sotirios Tetradis; Bruno Péault; Karen Lyons; Gustavo A Miranda-Carboni; Susan A Krum
Journal:  J Bone Miner Res       Date:  2014-12       Impact factor: 6.741

10.  A kinetic model identifies phosphorylated estrogen receptor-α (ERα) as a critical regulator of ERα dynamics in breast cancer.

Authors:  Dan Tian; Natalia M Solodin; Prashant Rajbhandari; Kelsi Bjorklund; Elaine T Alarid; Pamela K Kreeger
Journal:  FASEB J       Date:  2015-02-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.